Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTarsus Regulatory News (TRS)

  • There is currently no data for TRS

Interim Management Statement

5 May 2011 07:00

RNS Number : 9726F
Tarsus Group PLC
05 May 2011
 



 

5 May 2011

 

 

TARSUS GROUP plc

 

Interim Management Statement

 

On track for the full year - forward bookings accelerating

 

Tarsus Group Plc ("Tarsus" or "the Group"), the international business-to-business media group, is today publishing its Interim Management Statement relating to the period from the publication of its Preliminary Results on 7 March 2011 to 5 May 2011.

 

Trading Performance

 

Trading for the period and forward bookings for the full year have been positive and remain in-line with the Board's expectations. A summary of major developments includes:

 

§ US

 

As previously indicated the February 2011 Off-Price Show in Las Vegas performed well with revenues up 10%. The broadening of the offer to retailers by the inclusion of footwear and accessories has been a major factor in this division's success. Bookings for the August show are good.

 

The Medical division demonstrated good growth driven by our education programmes including those now delivered online. There have been a number of events in the period the largest of which was the April Orlando event which produced revenues 2% ahead of last year. This division continues to grow its total revenues at a double digit rate.

 

§ France

 

The trends that we experienced in the second half of 2010 continued into the first 4 months of 2011 with the portfolio stabilising. Mod'amont, our largest event in the period, was the same size as its February 2010 edition and was well received by our customers with a good increase in visitors. The smaller IT and services exhibitions in April produced revenues behind last year's editions but, encouragingly for the future, grew their attendances by 8%.

 

§ Emerging Markets

 

Our Emerging Markets business continued to gain momentum with strong revenue growth. In the period, we held a number of events in the Middle East which all demonstrated good performances and, very encouragingly, across the board attendances at these events were well ahead of their previous editions.

 

Financial Position

 

There have been no significant changes to the financial position of the Group since the publication of the Preliminary Results on 7 March 2011.

 

Outlook

 

We remain committed to our long term strategy of increasing our exposure to Emerging Markets (Project 50/13) and driving organic growth within the business. Activity in the exhibition market generally is picking up and we are seeing an increase in M&A opportunities which fit our criteria.

 

Within each two-year cycle, odd years are by far the larger in profit terms for the Group as they contain both Labelexpo Europe (in September) and the Dubai Airshow (in November). Bookings for Labelexpo Europe continue to improve and are now tracking over 10% up on its previous edition. The Dubai Airshow bookings are tracking in-line with its previous edition.

 

As in previous years, the Group's revenues remain heavily second-half weighted. Forward bookings continue to accelerate and now stand at 75% of anticipated full year revenues compared with 67% at the same time in 2010 (as adjusted for biennial events).

 

 

 

 

 

Tarsus Group plc:

 

Douglas Emslie, Group Managing Director 020 8846 2700

Ashley Milton, Group Finance Director 020 8846 2700

 

Media:

 

Madano Partnership

Matthew Moth 020 7593 4000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSDKQDPCBKDPPK
Date   Source Headline
8th Dec 20164:35 pmRNSHolding(s) in Company
8th Dec 20164:33 pmRNSHolding(s) in Company
8th Dec 20164:31 pmRNSHolding(s) in Company
8th Dec 20164:29 pmRNSHolding(s) in Company
8th Dec 20167:00 amRNSCompletion of Acquisition
7th Dec 20169:00 amRNSAdmission of Placing Shares
5th Dec 201612:30 pmRNSCompletion of Placing
5th Dec 20167:00 amRNSProposed Placing and Acquisition
1st Dec 201610:46 amRNSTotal Voting Rights
22nd Nov 20167:00 amRNSCapital Markets Event and Trading Update
9th Nov 20163:19 pmRNSBlock listing Interim Review
31st Oct 20169:52 amRNSTotal Voting Rights
13th Oct 20167:24 amRNSDirector/PDMR Shareholding
12th Oct 20167:00 amRNSTrading Update
30th Sep 20169:53 amRNSTotal Voting Rights and Capital
1st Sep 201612:09 pmRNSTotal Voting Rights
15th Aug 20165:28 pmRNSInterim financial statements
9th Aug 20166:11 pmRNSHolding(s) in Company
29th Jul 201612:10 pmRNSTotal Voting Rights and Capital
27th Jul 20167:00 amRNSHalf-year Report
11th Jul 20161:30 pmRNSApplication for Admission
5th Jul 20161:12 pmRNSHolding(s) in Company
30th Jun 201612:28 pmRNSTotal Voting Rights
21st Jun 20164:42 pmRNSDirector/PDMR Shareholding
20th Jun 20164:00 pmRNSResult of AGM
7th Jun 20161:15 pmRNSDirector/PDMR Shareholding
3rd Jun 20162:58 pmRNSScrip Dividend Circular (the "Circular")
31st May 201611:59 amRNSTotal Voting Rights and Capital
17th May 20163:08 pmRNSNotice of 2016 Annual General Meeting
17th May 20167:00 amRNSTrading Update
11th May 20167:00 amRNSDirector/PDMR Shareholding
9th May 20163:43 pmRNSBlock Listing Six Monthly Return
29th Apr 20164:14 pmRNSTotal Voting Rights
31st Mar 20162:25 pmRNSTotal Voting Rights
31st Mar 20162:24 pmRNSDirector/PDMR Shareholding
21st Mar 20163:11 pmRNS2015 Annual Report
8th Mar 20165:55 pmRNSDirector/PDMR Shareholding
3rd Mar 20164:47 pmRNSDirector/PDMR Shareholding
2nd Mar 20167:00 amRNSFinal Results
2nd Feb 20163:48 pmRNSTotal Voting Rights and Capital
25th Jan 20161:05 pmRNSApplication for Admission
12th Jan 20167:00 amRNSYear-end trading update
31st Dec 20159:25 amRNSTotal Voting Rights
14th Dec 20155:07 pmRNSScrip dividend circular
8th Dec 20157:00 amRNSCapital markets presentation
2nd Dec 20153:49 pmRNSDirector/PDMR Shareholding
30th Nov 20154:35 pmRNSTotal Voting Rights
11th Nov 201510:00 amRNSBlock Listing Six Monthly Return
30th Oct 20153:22 pmRNSDirector/PDMR Shareholding
30th Oct 20153:20 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.